- Home
- APRE vs MGRX Comparison
APRE vs MGRX Comparison
Compare APRE & MGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APRE
- MGRX
- Stock Information
- Founded
- APRE 2006
- MGRX 2021
- Country
- APRE United States
- MGRX United States
- Employees
- APRE N/A
- MGRX N/A
- Industry
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- MGRX Computer Software: Prepackaged Software
- Sector
- APRE Health Care
- MGRX Technology
- Exchange
- APRE Nasdaq
- MGRX Nasdaq
- Market Cap
- APRE 9.7M
- MGRX 8.1M
- IPO Year
- APRE 2019
- MGRX 2023
- Fundamental
- Price
- APRE $1.65
- MGRX $1.78
- Analyst Decision
- APRE Strong Buy
- MGRX
- Analyst Count
- APRE 2
- MGRX 0
- Target Price
- APRE $15.50
- MGRX N/A
- AVG Volume (30 Days)
- APRE 17.1K
- MGRX 438.4K
- Earning Date
- APRE 05-20-2025
- MGRX 05-19-2025
- Dividend Yield
- APRE N/A
- MGRX N/A
- EPS Growth
- APRE N/A
- MGRX N/A
- EPS
- APRE N/A
- MGRX N/A
- Revenue
- APRE $1,502,581.00
- MGRX $615,873.00
- Revenue This Year
- APRE N/A
- MGRX N/A
- Revenue Next Year
- APRE N/A
- MGRX N/A
- P/E Ratio
- APRE N/A
- MGRX N/A
- Revenue Growth
- APRE 157.63
- MGRX N/A
- 52 Week Low
- APRE $1.41
- MGRX $1.49
- 52 Week High
- APRE $5.90
- MGRX $16.80
- Technical
- Relative Strength Index (RSI)
- APRE 41.84
- MGRX 41.28
- Support Level
- APRE $1.67
- MGRX $1.65
- Resistance Level
- APRE $1.99
- MGRX $2.00
- Average True Range (ATR)
- APRE 0.14
- MGRX 0.30
- MACD
- APRE 0.04
- MGRX 0.05
- Stochastic Oscillator
- APRE 41.55
- MGRX 19.19
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.